Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Gandara

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering resultsO S Breathnach, B Freidlin, B Conley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology GroupP A Bunn, J Crowley, K Kelly, et al.
British Journal of Cancer|April 22, 2015
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomasZ Eroglu, H A Tawbi, J Hu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 3, 2020
Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trialsM Chalabi, A Cardona, D R Nagarkar, et al.
The Cancer Journal From Scientific American|April 3, 1999
A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group studyV K Sondak, P Y Liu, L E Flaherty, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 23, 2002
Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trialC M Moinpour, B Lyons, P K Grevstad, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1996
Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamideP J Hesketh, D R Gandara, A M Hesketh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group studyK Kelly, J J Crowley, P A Bunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesisP J Hesketh, W K Murphy, E P Lester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology GroupD R Gandara, J Crowley, R B Livingston, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering resultsO S Breathnach, B Freidlin, B Conley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology GroupP A Bunn, J Crowley, K Kelly, et al.
British Journal of Cancer|April 22, 2015
A randomised phase II trial of selumetinib vs selumetinib plus temsirolimus for soft-tissue sarcomasZ Eroglu, H A Tawbi, J Hu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 3, 2020
Efficacy of chemotherapy and atezolizumab in patients with non-small-cell lung cancer receiving antibiotics and proton pump inhibitors: pooled post hoc analyses of the OAK and POPLAR trialsM Chalabi, A Cardona, D R Nagarkar, et al.
The Cancer Journal From Scientific American|April 3, 1999
A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group studyV K Sondak, P Y Liu, L E Flaherty, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 23, 2002
Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trialC M Moinpour, B Lyons, P K Grevstad, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 1996
Dose-ranging evaluation of the antiemetic efficacy of intravenous dolasetron in patients receiving chemotherapy with doxorubicin or cyclophosphamideP J Hesketh, D R Gandara, A M Hesketh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group studyK Kelly, J J Crowley, P A Bunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
GR 38032F (GR-C507/75): a novel compound effective in the prevention of acute cisplatin-induced emesisP J Hesketh, W K Murphy, E P Lester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology GroupD R Gandara, J Crowley, R B Livingston, et al.
Pageof 9